Evotec acquires Kinaxo; expands discovery and development platform.
German biotech firm Evotec has expanded its drug discovery and early development platform with the acquisition of Munich-based chemical proteomics specialists, Kinaxo.
German biotech firm Evotec has expanded its drug discovery and early development platform with the acquisition of Munich-based chemical proteomics specialists, Kinaxo.
A pool of research-aware US oncology clinical investigators must be developed to ensure patient recruitment rates meet demand.
Valutek hopes new reusable cleanroom glove will help pharma researchers wave goodbye to laboratory discomfort.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at PhRMA, BIO, Shire, Eli Lilly and DPT Laboratories.
Shamla Pharmaceutical Industries has announced it will build a manufacturing facility in King Abdullah Economic City (KAEC), Saudi Arabia.
US-based Numira Biosciences has expanded its imaging and pre-clinical services portfolio after acquiring the efficacy pharmacology operating unit of Ricerca Biosciences.
Unilife saw its losses increase in the second quarter of fiscal 2011 on the lack of industrialisation revenue, higher R&D spending and the cost of its move to the US.